NEUROPATHIC PAIN

 

The perceived effects of smoked cannabis on patients with multiple sclerosis (abst – 1997)            http://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=13

 

Meta-analysis of cannabis based treatments for neuropathic and multiple sclerosis-related pain.   (abst – 1997)  http://www.unboundmedicine.com/medline/ebm/record/17257464/abstract/Meta_analysis_of_cannabis_bas ed_treatments_for_neuropathic_and_multiple_sclerosis_related_pain

 

Analgesic effect of the cannabinoid analogue nabilone is not mediated by opioid receptors.          (abst – 1999)

http://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=203

 

Cannabinoid Receptor Messenger Rna Levels Decrease in a Subset of Neurons of the Lateral Striatum, Cortex and Hippocampus of Transgenic Huntington’s Disease Mice. (abst – 2000)        http://www.ncbi.nlm.nih.gov/pubmed/10891614

 

The synthetic cannabinoid WIN55,212-2 attenuates hyperalgesia and allodynia in a rat model of neuropathic pain                                                               (full – 2001)  http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1572814&tool=pmcentrez

 

The potent emetogenic effects of the endocannabinoid, 2-AG (2-arachidonoylglycerol) are blocked by delta(9)-tetrahydrocannabinol and other cannnabinoids.                                                            (full – 2002)  http://jpet.aspetjournals.org/content/300/1/34.long

 

Whether whole plant Cannabis extracts can improve intractable neurogenic symptoms? (full – 2003)                                         http://www.ukcia.org/research/WholePlantExtractsImproveNeurogenicSymptoms.pdf

 

Activation of CB2 cannabinoid receptors by AM1241 inhibits experimental neuropathic pain: Pain inhibition by receptors not present in the CNS                                                           (full – 2003)  http://www.pnas.org/content/100/18/10529.full

 

Analgesic effect of the synthetic cannabinoid CT-3 on chronic neuropathic pain: a randomized controlled trial.  (full – 2003)

http://jama.ama-assn.org/cgi/content/full/290/13/1757?ijkey=b86f3fe6d2018d53522ffca8e365fc2ff7aaf2fb

 

Randomised controlled trial of cannabis based medicinal extracts (CBME) in central neuropathic pain due to multiple sclerosis.                                                     (abst – 2003)

http://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=82

 

The effects of smoked cannabis in painful peripheral neuropathy and cancer pain refractory to opiods.    (abst – 2003)

http://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=96

 

New Compound That Acts On Peripheral Receptors May Be Promising Treatment For Some Nerve Pain (news – 2003)  http://www.sciencedaily.com/releases/2003/08/030812073750.htm

 

Initial experiences with medicinal extracts of cannabis for chronic pain: Results from 34 ‘N of 1’ studies            (full – 2004)                          http://www.ukcia.org/research/InitialExperiencesChronicPain.pdf

 

Efficacy of two cannabis based medicinal extracts for relief of central neuropathic pain from brachial plexus avulsion: results of a randomised controlled trial (full – 2004)  http://www.ukcia.org/research/CentralNeuropathicPainEfficacy.pdf

 

Are oral cannabinoids safe and effective in refractory neuropathic pain?              (abst – 2004)

http://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=143

 

Marijuana-like compounds may aid array of debiliating conditions ranging from Parkinson’s to pain         (news – 2004)

http://www.eurekalert.org/pub_releases/2004-10/sfn-mcm102604.php

 

Ajulemic acid (IP-751): Synthesis, proof of principle, toxicity studies, and clinical trials (full – 2005)                                       http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2751505/?tool=pubmed

 

Smoked cannabis therapy for HIV-related painful peripheral neuropathy: results of a randomized, placebo-controlled clinical trial.                                                  (abst – 2005)

http://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=172

 

Randomized, controlled trial of cannabis-based medicine in central pain in multiple sclerosis        (abst – 2005)                            http://www.neurology.org/cgi/content/abstract/65/6/812?etoc

 

Effects of a Cannabinoid Agonist on Spinal Nociceptive Neurons in a Rodent Model of Neuropathic Pain         (full – 2006)                                        http://jn.physiology.org/cgi/content/full/96/6/2984

 

Actions of the FAAH inhibitor URB597 in neuropathic and inflammatory chronic pain models    (full – 2006)                          http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1751298/?tool=pmcentrez

 

Cannabinoids In Medicine: A Review Of Their Therapeutic Potential                  (full – 2006)

http://www.doctordeluca.com/Library/WOD/WPS3-MedMj/CannabinoidsMedMetaAnalysis06.pdf

 

CB1 receptor selective activation inhibits beta-amyloid-induced iNOS protein expression in C6 cells and subsequently blunts tau protein hyperphosphorylation in co-cultured neurons.        (abst – 2006)                                     http://www.ncbi.nlm.nih.gov/pubmed/16837132

 

In MedPanel Summit, Leading Pain Experts Name Cannabinoids Among Most Promising Approaches to Treating Neuropathic Pain, Assert That Sociopolitical Climate Will Hamper Drug Approvals          (news – 2006)  http://www.redorbit.com/news/health/545812/in_medpanel_summit_leading_pain_experts_name_cannabin  oids_among_most/index.html?source=r_health

 

Endocannabinoid metabolism and uptake: novel targets for neuropathic and inflammatory pain   (full – 2007)                   http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2190014/?tool=pubmed

 

The fatty acid amide hydrolase inhibitor URB597 (cyclohexylcarbamic acid 3′- carbamoylbiphenyl-3-yl ester) reduces neuropathic pain after oral administration in mice. (full – 2007)                                   http://jpet.aspetjournals.org/content/322/1/236.long

 

Cannabinoid CB2 receptors: a therapeutic target for the treatment of inflammatory and neuropathic pain            (full – 2007)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2219541/?tool=pmcentrez

 

Meta-analysis of cannabis based treatments for neuropathic and multiple sclerosis-related pain.   (abst – 2007)                     http://www.ncbi.nlm.nih.gov/pubmed/17257464

 

Sativex successfully treats neuropathic pain characterised by allodynia: A randomised, double-blind, placebo-controlled clinical trial                                                    (abst – 2007)  http://www.ncbi.nlm.nih.gov/pubmed/17997224

 

Oromucosal delta9-tetrahydrocannabinol/cannabidiol for neuropathic pain associated with multiple sclerosis: an uncontrolled, open-label, 2-year extension trial.

(abst – 2007)              http://www.ncbi.nlm.nih.gov/pubmed/18035205

 

The synthetic cannabinoids attenuate allodynia and hyperalgesia in a rat model of trigeminal neuropathic pain.                                                           (abst – 2007)      http://www.ncbi.nlm.nih.gov/pubmed/17572451

 

Cannabis in painful HIV-associated sensory neuropathy: A randomized placebo- controlled trial.            (abst – 2007)

http://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=199

 

The local antinociceptive effects of paracetamol in neuropathic pain are mediated by cannabinoid receptors                                                   (abst – 2007)  http://www.sciencedirect.com/science/article/pii/S0014299907007935

 

Study Supports Medical Marijuana Use               (news – 2007)

http://www.drugfree.org/join-together/drugs/study-supports-medical

 

Smoked Cannabis Reduces Foot Pain Associated With HIV In Placebo Trial (news – 2007)                                       http://www.sciencedaily.com/releases/2007/02/070212185335.htm

 

 

 

 

 

 

 

 

 

Marijuana gives relief from chronic pain for AIDS sufferers               (news – 2007)

http://www.news-medical.net/news/2007/02/14/21906.aspx

 

Cannabis may be safe and effective for HIV-related neuropathic pain             (news – 2007)

http://www.aidsmap.com/en/news/E0578F66-B327-4504-836D-DEE790B87A0F.asp

 

Marijuana, Very Efficient in Cutting Off HIV Related Nerve Pain             (news – 2007)  http://news.softpedia.com/news/Marijuana-Very-Efficient-in-Cutting-off-HIV-Related-Nerve-Pain-   47003.shtml

 

Smoked Cannabis Proven Effective In Treating Neuropathic Pain            (news – 2007)

http://www.sciencedaily.com/releases/2007/10/071024141745.htm

 

Selective Activation of Cannabinoid CB2 Receptors Suppresses Neuropathic Nociception Induced by Treatment with the Chemotherapeutic Agent Paclitaxel in Rats (full – 2008)  http://jpet.aspetjournals.org/content/327/2/584.full#content-block

 

Crucial Role of CB2 Cannabinoid Receptor in the Regulation of Central Immune Responses during Neuropathic Pain                                                                   (full – 2008)  http://www.jneurosci.org/cgi/content/full/28/46/12125

 

MDA7: a novel selective agonist for CB2 receptors that prevents allodynia in rat neuropathic pain models.         (full – 2008)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2597252/

 

Double Blind, Placebo Controlled Trial of Smoked Marijuana on Neuropathic Pain (full – 2008)                                 http://www.cmcr.ucsd.edu/images/pdfs/Wilsey_2008.pdf

 

Comparison of analgesic effects and patient tolerability of nabilone and dihydrocodeine for chronic neuropathic pain: randomised, crossover, double blind study.                                                   (full – 2008)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2213874/?tool=pubmed

 

Design and synthesis of a novel series of N-alkyl isatin acylhydrazone derivatives that act as selective cannabinoid receptor 2 agonists for the treatment of neuropathic pain.

(abst – 2008)               http://www.ncbi.nlm.nih.gov/pubmed/18666769

 

Involvement of central cannabinoid CB2 receptor in reducing mechanical allodynia in a mouse model of neuropathic pain                                           (abst – 2008)  http://www.sciencedirect.com/science/article/pii/S0014299908000630

 

Differential effects of repeated low dose treatment with the cannabinoid agonist WIN 55,212-2 in experimental models of bone cancer pain and neuropathic pain.

(abst – 2008)                http://www.ncbi.nlm.nih.gov/pubmed/18611408

 

Antihyperalgesic effect of a Cannabis sativa extract in a rat model of neuropathic pain: mechanisms involved.                                                 (abst – 2008)        http://www.ncbi.nlm.nih.gov/pubmed/18618522

 

Medicinal Marijuana Effective For Neuropathic Pain In HIV, Study Finds (news – 2008)                                     http://www.sciencedaily.com/releases/2008/08/080806113135.htm

 

Marijuana May Be Effective For Neuropathic Pain                (news – 2008)

http://www.sciencedaily.com/releases/2008/06/080626150628.htm

 

Tetrahydrocannabinol (Delta 9-THC) Treatment in Chronic Central Neuropathic Pain and Fibromyalgia Patients: Results of a Multicenter Survey                                                            (full – 2009)  http://www.hindawi.com/journals/arp/2009/827290.html

 

Sustained antinociceptive effect of cannabinoid receptor agonist WIN 55,212-2 over time in rat model of neuropathic spinal cord injury pain                                        (full – 2009)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2743245/?tool=pmcentrez

 

Neuropathic Pain and Endocannabinoid-Degradation Blockade             (full – 2009)

http://jpet.aspetjournals.org/content/330/3/669.1.full?sid=af53ea87-ab4b-426e-9c7e-8f750e9c4a17

 

Blockade of endocannabinoid-degrading enzymes attenuates neuropathic pain. (full – 2009)

http://jpet.aspetjournals.org/content/330/3/902.full?sid=af53ea87-ab4b-426e-9c7e-8f750e9c4a17

 

Minocycline treatment inhibits microglial activation and alters spinal levels of endocannabinoids in a rat model of neuropathic pain                                                                         (full – 2009)  http://www.molecularpain.com/content/5/1/35

 

Cannabinoids as pharmacotherapies for neuropathic pain: from the bench to the bedside. (full – 2009)                                        http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2755639/

 

Beneficial effects of a Cannabis sativa extract treatment on diabetes-induced neuropathy and oxidative stress.                                                  (abst – 2009)  http://www.unboundmedicine.com/medline/ebm/record/19441010/abstract/

 

Medical Marijuana and Peripheral Neuropathy                 (news – 2009)

https://www.marijuanadoctors.com/content/ailments/view/116?ailment=peripheral-neuropathy

 

Cannabinoid-mediated modulation of neuropathic pain and microglial accumulation in a model of murine type I diabetic peripheral neuropathic pain                                                        (full – 2010)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2845559/?tool=pmcentrez

 

R-Flurbiprofen Reduces Neuropathic Pain in Rodents by Restoring Endogenous Cannabinoids    (full – 2010)                                     http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2869361/

 

Pharmacological Treatment of Painful HIV-Associated Sensory Neuropathy: A Systematic Review and Meta-Analysis of Randomised Controlled Trials                                                             (full – 2010)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3010990/?tool=pmcentrez

 

Smoked cannabis for chronic neuropathic pain: a randomized controlled trial (full – 2010)                                    http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2950205/?tool=pmcentrez

 

Pharmacological characterization of a novel cannabinoid ligand, MDA19, for treatment of neuropathic pain.      (full – 2010)                               http://www.anesthesia-analgesia.org/content/111/1/99.long

 

Misdiagnosed chronic pelvic pain: pudendal neuralgia responding to a novel use of palmitoylethanolamide.                                                      (abst – 2010)    http://www.ncbi.nlm.nih.gov/pubmed/20345619

 

An Open-Label Comparison of Nabilone and Gabapentin as Adjuvant Therapy or Monotherapy in the Management of Neuropathic Pain in Patients with Peripheral Neuropathy.        (abst – 2010)

http://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=311

 

Effect of dronabinol on central neuropathic pain after spinal cord injury: a pilot study. (abst – 2010)                                     http://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=313

 

Cannabinoid subtype-2 receptors modulate the antihyperalgesic effect of WIN 55,212-2 in rats with neuropathic spinal cord injury pain.                                                      (abst – 2010)  http://www.ncbi.nlm.nih.gov/pubmed/20920894

 

Study Claims Cannabis Reduces Chronic Pain               (news – 2010)

http://www.redorbit.com/news/health/1909943/study_claims_cannabis_reduces_chronic_pain/index.html

 

Cannabinoids inhibit and may prevent neuropathic pain in diabetes.              (news – 2010)

http://medigardens.blogspot.com/2010/04/march-2010-cannabinoids-inhibit-and-may.html

 

Study: Smoking pot may ease chronic pain                (news – 2010)

http://www.cnn.com/2010/HEALTH/08/30/health.pot.reduce.pain/

 

Brief Report: Cannabidiol Prevents the Development of Cold and Mechanical Allodynia in Paclitaxel-Treated Female C57Bl6 Mice.                                                    (full – 2011)

http://www.anesthesia-analgesia.org/content/113/4/947.long

 

Cannabinoid Agonists Inhibit Neuropathic Pain Induced by Brachial Plexus Avulsion in Mice by Affecting Glial Cells and MAP Kinases.                                                     (full – 2011)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3172222/?tool=pubmed

 

Mutations in ABHD12 cause the neurodegenerative disease PHARC: An inborn error of endocannabinoid metabolism.                                            (full – 2011)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2933347/?tool=pubmed

 

Spinal cannabinoid CB2 receptors as a target for neuropathic pain: an investigation using chronic constriction injury.                                                        (abst – 2011)       http://www.ncbi.nlm.nih.gov/pubmed/22210507

 

Cannabinoids for Treatment of Chronic Non-Cancer Pain; a Systematic Review of Randomized Trials.   (abst – 2011)                                    http://www.ncbi.nlm.nih.gov/pubmed/21426373

 

Cannabidiol as an emergent therapeutic strategy for lessening the impact of inflammation on oxidative stress.                                              (abst – 2011)            http://www.ncbi.nlm.nih.gov/pubmed/21238581

 

Self-medication of a cannabinoid CB(2) agonist in an animal model of neuropathic pain. (abst – 2011)  http://www.unboundmedicine.com/medline/ebm/record/21550725/abstract/Self_medication_of_a_cannabin

 

 

 

Activation of spinal and supraspinal cannabinoid-1 receptors leads to antinociception in a rat model of neuropathic spinal cord injury pain.                                                         (abst – 2011)  http://www.ncbi.nlm.nih.gov/pubmed/21813113

 

Cannabinoid ‘Completely’ Prevents Chemotherapy-Induced Neuropathy, Study Says (news – 2011)                                    http://www.norml.org/index.cfm?Group_ID=8710

 

Marijuana component may ease pain from chemo therapy drugs              (news – 2011)

http://www.jpost.com/Health/Article.aspx?id=241299

 

Cannabidiol may help prevent paclitaxel-induced peripheral neuropathy             (news – 2011)  http://www.news-medical.net/news/20110926/Cannabidiol-may-help-prevent-paclitaxel-induced-  peripheral-neuropathy.aspx

 

Prescribing Cannabis for Harm Reduction.               (full – 2012)

http://www.harmreductionjournal.com/content/pdf/1477-7517-9-1.pdf

 

The maintenance of cisplatin- and paclitaxel-induced mechanical and cold allodynia is suppressed by cannabinoid CB2 receptor activation and independent of CXCR4 signaling in models of chemotherapy-induced peripheral neuropathy                                                                                           (full – 2012)  http://www.molecularpain.com/content/8/1/71

 

Therapeutic utility of palmitoylethanolamide in the treatment of neuropathic pain associated with various pathological conditions: a case series                                                       (full – 2012)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3500919/

 

Dynamic changes to the endocannabinoid system in models of chronic pain (abst – 2012)                                      http://www.ncbi.nlm.nih.gov/pubmed/23108548

 

The atypical cannabinoid O-1602 increases hind paw sensitisation in the chronic constriction injury model of neuropathic pain.                                                             (abst – 2012)  http://www.ncbi.nlm.nih.gov/pubmed/22227298

 

Cannabinoid agonist WIN 55,212-2 prevents the development of paclitaxel-induced peripheral neuropathy in rats. Possible involvement of spinal glial cells.                                                               (abst – 2012)  http://www.ncbi.nlm.nih.gov/pubmed/22374260

 

Low brain penetrant CB1 receptor agonists for the treatment of neuropathic pain. (abst – 2012)                                   http://www.ncbi.nlm.nih.gov/pubmed/22421020

 

Modulation of neuropathic-pain-related behaviour by the spinal endocannabinoid/endovanilloid system  (abst – 2012)  http://www.ncbi.nlm.nih.gov/pubmed/23108547

 

 

 

 

 

 

 

 

Cannabinoids suppress inflammatory and neuropathic pain by targeting α3 glycine receptors.       (abst – 2012)                              http://www.ncbi.nlm.nih.gov/pubmed/22585736

 

Characterization of cannabinoid-induced relief of neuropathic pain in rat models of type 1 and type 2 diabetes.                                             (abst – 2012)           http://www.ncbi.nlm.nih.gov/pubmed/22609797

 

Prevention of Paclitaxel-Induced Neuropathy Through Activation of the Central Cannabinoid Type 2 Receptor System                                                                   (abst – 2012)

http://www.anesthesia- analgesia.org/content/114/5/1104.abstract?maxtoshow=&hits=25&RESULTFORMAT=&fulltext=cannabi  noid&searchid=1&FIRSTINDEX=130&sortspec=date&resourcetype=HWCIT

 

A Randomized, Double-Blind, Placebo Controlled, Parallel Assignment, Flexible Dose, Efficacy Study of Nabilone as Adjuvant in the Treatment of Diabetic Peripheral Neuropathic Pain Using an Enriched Enrollment Randomized Withdrawal Design (S38.003)           (abst – 2012)

http://www.neurology.org/cgi/content/meeting_abstract/78/1_MeetingAbstracts/S38.003?maxtoshow=&hit  s=25&RESULTFORMAT=&fulltext=cannabinoid&searchid=1&FIRSTINDEX=180&sortspec=date&reso  urcetype=HWCIT

 

The Novel Reversible Fatty Acid Amide Hydrolase Inhibitor ST4070 Increases Endocannabinoid Brain Levels and Counteracts Neuropathic Pain in Different Animal Models (abst – 2012)  http://jpet.aspetjournals.org/content/342/1/188.abstract?sid=ae58f15a-06bb-4a81-b850-61bb89fd59f5

 

An enriched-enrolment, randomized withdrawal, flexible-dose, double-blind, placebo- controlled, parallel assignment efficacy study of nabilone as adjuvant in the treatment of diabetic peripheral neuropathic pain.                                                                           (abst – 2012)  http://www.ncbi.nlm.nih.gov/pubmed/22921260

 

Peripheral antinociceptive effect of anandamide and drugs that affect the endocannabinoid system on the formalin test in normal and streptozotocin-diabetic rats. (abst – 2012)           http://www.ncbi.nlm.nih.gov/pubmed/22959964

 

The maintenance of cisplatin- and paclitaxel-induced mechanical and cold allodynia is suppressed by cannabinoid CB2 receptor activation and independent of CXCR4 signaling in models of chemotherapy-induced peripheral neuropathy.                                                                                          (abst – 2012)  http://www.ncbi.nlm.nih.gov/pubmed/22998838

 

A double-blind, randomized, placebo-controlled, parallel-group study of THC/CBD oromucosal spray in combination with the existing treatment regimen, in the relief of central neuropathic pain in patients with multiple sclerosis.                                                                                                (abst – 2012)  http://www.ncbi.nlm.nih.gov/pubmed/23180178

 

The therapeutic potential of cannabis and cannabinoids.                 (abst – 2012)

http://www.ncbi.nlm.nih.gov/pubmed/23008748

 

Alterations in endocannabinoid tone following chemotherapy-induced peripheral neuropathy: Effects of endocannabinoid deactivation inhibitors targeting fatty-acid amide

 

hydrolase and monoacylglycerol lipase in comparison to reference analgesics following cisplatin treatment.                                             (abst – 2012)        http://www.ncbi.nlm.nih.gov/pubmed/23127915

 

Palmitoylethanolamide is a new possible pharmacological treatment for the inflammation associated with trauma.                                                                        (abst – 2012)  http://www.ncbi.nlm.nih.gov/pubmed/22697514?dopt=Abstract

 

Low-Dose Vaporized Cannabis Significantly Improves Neuropathic Pain.            (abst – 2012)

http://www.ncbi.nlm.nih.gov/pubmed/23237736

 

Prevention of paclitaxel-induced neuropathy through activation of the central cannabinoid type 2 receptor system.                                                                              (abst – 2012)  http://www.ncbi.nlm.nih.gov/pubmed/22392969

 

California pot research backs therapeutic claims                 (news – 2012)

http://www.sacbee.com/2012/07/12/4625608/california-pot-research-backs.html

 

Cannabis as Painkiller                  (news – 2012)

http://www.sciencedaily.com/releases/2012/08/120807101232.htm

 

Study: Synthetic THC Analogue Mitigates Diabetic Neuropathy, Is ‘Well Tolerated’ In Patients   (news – 2012)

http://norml.org/news/2012/09/20/study-synthetic-thc-analogue-mitigates-diabetic-neuropathy-is-well-  tolerated-in-patients

 

New drug offers novel pain management therapy for diabetics.               (news – 2012)  http://www.thefreelibrary.com/New+drug+offers+novel+pain+management+therapy+for+diabetics.-  a0306899453

 

Synthetic cannabinoid could treat pain in diabetes patients                (news – 2012)  http://www.medwirenews.com/57/102248/Diabetes/Synthetic_cannabinoid_could_treat_pain_in_diabetes_ patients_.html

 

Drug offers new pain management therapy for diabetics              (news – 2012)

http://medicalxpress.com/news/2012-10-drug-pain-therapy-diabetics.html

 

The role of endocannabinoids in pain modulation.               (full – 2013)

http://onlinelibrary.wiley.com/doi/10.1111/fcp.12008/pdf

 

Drug design for neuropathic pain regulation from traditional chinese medicine. (abst – 2013)                                  http://www.ncbi.nlm.nih.gov/pubmed/23378894

 

Study: Vaporized, Low-Potency Cannabis Mitigates Neuropathic Pain             (news – 2013)

http://blog.norml.org/2013/01/03/study-vaporized-low-potency-cannabis-mitigates-neuropathic-pain/

 

Palmitoylethanolamide reduces formalin-induced neuropathic-like behaviour through spinal glial/microglial phenotypical changes in mice.                                                        (abst – 2013)  http://www.ncbi.nlm.nih.gov/pubmed/23394524

Share a link for